Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination
Caitlin M. Brumfiel, Meera H. Patel, David J. DiCaudo, Allison Rosenthal, Mark R. Pittelkow, Aaron R. Mangold
Abstract
"Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination." Leukemia & Lymphoma, 62(10), pp. 2554–2555 Disclosure statementThe authors have no financial disclosures or conflicts of interest associated with this work. Appropriate consent from the patient was obtained.
Topics & Concepts
CD30MedicineVaccinationLymphoproliferative disordersCoronavirus disease 2019 (COVID-19)LymphomaInternal medicineLeukemia2019-20 coronavirus outbreakOncologyPediatricsImmunologyPathologyOutbreakDiseaseInfectious disease (medical specialty)Cutaneous lymphoproliferative disorders researchCAR-T cell therapy researchImmunotherapy and Immune Responses